Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DR26FNM1C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,386
Award facts
- Contract value 100% obligated
- $10,386.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,386.27 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors, with a firm fixed price arrangement and ultimate completion date of November 5, 2025. This non-set-aside contract represents a competitive award to support federal pharmaceutical procurement needs, with the place of performance located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement running through December 2026 that enables the supply of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly for Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA covering diverse pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. As a major for-profit pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen continues to compete successfully in federal procurement for medical supply chain requirements and is positioned to potentially participate in the DLA Troop Support's planned Pharmaceutical Prime Vendor Global Program Generation V regional contracts.
Quick answers
Who was awarded contract SPE2DR26FNM1C?
SPE2DR26FNM1C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FNM1C worth?
The government has obligated $10,386 on SPE2DR26FNM1C.
Is contract SPE2DR26FNM1C an order under another contract?
Yes. SPE2DR26FNM1C is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNM1C competed?
The extent of competition for SPE2DR26FNM1C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award